Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Olga Voronel
Observed institutions:
Wayne State University,
Albany Medical College,
Albany Medical Center Hospital
OpenAlex ID:
A5028994467
Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2019
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
·
Molecular Cancer Research
·
17
Cerebral Blastomycosis: Radiologic-Pathologic Correlation of Solitary CNS Blastomycosis Mass-Like Infection
2015
·
Costas Stavrakis
, Ananth Narayan
, et al.
·
Journal of Clinical Imaging Science
·
14
Biomarkers of immune checkpoint inhibitor response in metastatic breast cancer: PD-L1 protein expression, CD274 gene amplification, and total mutational burden.
2016
·
Jeffrey S. Ross
, Laurie M Gay
, et al.
·
Journal of Clinical Oncology
·
2
Comparative assessment of conventional chromosomal analysis and fluorescence in situ hybridization in the evaluation of suspected myelodysplastic syndromes: A single institution experience
2019
·
Denyo Adjoa Zakhia
, Olga Voronel
, et al.
·
Avicenna Journal of Medicine
·
1
PDF
Figure S7 from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
PDF
Figure S4 (A,B) from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
Figure S5(A,B) from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
PDF
Figure S3(A-C) from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
Data from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
Figure S6 from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
Figure S2 from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
PDF
Figure S1 from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
Figure S6 from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
PDF
Figure S2 from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
Data from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
Supplementary materials from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
Figure S3(A-C) from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
PDF
Figure S4 (A,B) from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
PDF
Figure S7 from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
Supplementary materials from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
Figure S5(A,B) from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
Figure S1 from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
2023
·
Timothy F. Day
, Bhaskar V.S. Kallakury
, et al.
PDF
Abstract 4343: Prognostic significance of CBP (CREB-binding protein) in prostatic adenocarcinomas (PACs): CBP is associated with high grade, advanced stage and biochemical disease recurrence
2015
·
Jeffrey S. Ross
, Olga Voronel
, et al.
·
Cancer Research
Abstract 4724: Adverse prognostic significance of TNFAIP8 protein expression in non small cell lung cancer
2014
·
Bhaskar V. Kallakury
, Usha N. Kasid
, et al.
·
Cancer Research
Show more works
View as search
Works count:
24
Citation count:
34
H-index:
2
I10-index:
2
Year
Topic
Type